<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Accumulating data have shown that the level of serum <z:chebi fb="0" ids="17230">homocysteine</z:chebi> in patients with mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> is higher than <z:mpath ids='MPATH_458'>normal</z:mpath> while the underlying mechanism is not fully understood </plain></SENT>
<SENT sid="1" pm="."><plain>Here, a hyperhomocysteinemic rat model was made by maintaining rats on a diet high in methionine </plain></SENT>
<SENT sid="2" pm="."><plain>The cognitive behavior, level of <z:chebi fb="3" ids="25375">monoamine</z:chebi> <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi> in brain homogenates and brain-derived neurotrophic factor (BDNF) in cerebral spinal fluid (CSF) were compared between high-methionine diet and control group </plain></SENT>
<SENT sid="3" pm="."><plain>The high-methionine diet group presented longer mean latency of escape and lesser time in target quadrant in morris maze test, lower level of <z:chebi fb="19" ids="28790">serotonin</z:chebi> and <z:chebi fb="40" ids="18243">dopamine</z:chebi> in cortex homogenates and lower level of BDNF in CSF </plain></SENT>
<SENT sid="4" pm="."><plain>Together, our findings provide evidence that <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> could cause alterations of <z:chebi fb="3" ids="25375">monoamine</z:chebi> and neurotrophic factor, which might be further pathogenetic mechanisms underlying the <z:e sem="disease" ids="C0854193" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive deterioration</z:e> </plain></SENT>
</text></document>